Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD-L1 inhibition to ongoing clinical studies.
Ontology highlight
ABSTRACT: Combined TGFβ/PD-L1 inhibition is currently undergoing clinical trials in multiple cancer types. The early reported clinical trials of bintrafusp alfa, a bifunctional fusion protein targeting both of these pathways, have had mixed results. Here, we briefly review recent preclinical advances that can be used to refine these ongoing clinical trials and improve their outcomes.
SUBMITTER: Strait AA
PROVIDER: S-EPMC8799489 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA